Posts
February 26 2020
Lianluo Smart Limited announced the closing of their registered direct offering in the amount of $2,500,000. EGS acted as counsel to Maxim Group LLC, the sole placement agent for the offering.
February 24 2020
East Stone Acquisition Corp. announced the closing of its initial public offering in the amount of $138,000,000. EGS acted as counsel to East Stone.
February 21 2020
Adamis Pharmaceuticals Corporation announced the closing of their registered direct offering in the amount of $6,700,000. EGS acted as counsel to Maxim Group LLC, the sole placement agent in the offering.
February 20 2020
TKK Symphony Acquisition Corporation and Glory Star New Media Group Limited announce the closing of their business combination. EGS acted as counsel to TKK Symphony.
February 18 2020
Client Alert: USCIS Releases Updated Form I-9
The United States Citizenship and Immigration Services (USCIS) released a new version of the Form I-9, Employment Eligibility Verification, available here. This new form and its instructions contain minor revisions. Employers are advised to begin using this updated Form I-9 immediately, even though the former version remains effective until April 30, 2020. After April 30, 2020, the former version, 07/17/2017N, will no longer be valid for use and employers who fail to use the new version may be subject to penalties.
Click here to read the alert.
February 18 2020
Yunhong International, a company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities, announced closing of upsized $60,000,000 initial public offering.
February 14 2020
Lianluo Smart Limited, a China based professional smart service and products provider, announced the closing of their registered direct offering in the amount of $2,200,000. EGS acted as counsel to Maxim Group LLC, the sole placement agent for the offering.
February 14 2020
Integrity Applications, Inc., a medical device company focused on the design, development and commercialization of non-invasive glucose monitoring devices, closed on a private offering of shares of its common stock for gross proceeds of $15,000,000. EGS acted as counsel for Andrew Garett, Inc., the sole placement agent in the offering.